Publications by authors named "Asma Alkheraiji"
Article Synopsis
- Adalimumab is commonly used for treating autoimmune and inflammatory skin diseases, but it can cause rare side effects like lichenoid drug eruptions.
- A case was reported of a 62-year-old woman with ulcerative colitis who developed this skin issue two weeks after starting adalimumab, confirmed by a skin biopsy.
- Managing such cases requires careful assessment, as stopping the medication may worsen the original autoimmune condition, emphasizing the need for early intervention and a team-based healthcare approach.
A cross-sectional study was conducted between March and August 2021; an electronic survey was administered to all dermatology residents (n=79) in all centers with the Saudi Board Dermatology Training Program in the western, eastern and southern regions. Participation was voluntary, and written informed consent was obtained before the study. The survey was completed by 70 dermatology residents, for an 88.
View Article and Find Full Text PDF